| |
article
|
1. Borovcanin Milica, Jovanovic I., Radosavljevic Gordana, Djukić Dejanović S., Banković D., Arsenijevic Nebojsa, Lukic Miodrag, Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse, null, 10.1016/j.jpsychires.2012.08.016 (ISSN 0022-3956)
|
2. Borovcanin Milica, Jovanovic I., Radosavljevic Gordana, Djukić Dejanović S., Stefanovic V., Arsenijevic Nebojsa, Lukic Miodrag, Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response, null, 10.1016/j.schres.2013.03.027 (ISSN 0920-9964)
|
3. Stefanovic Vesna, Mihajlovic Goran, Nenadović Milutin, Đukić Dejanović Slavica, Borovcanin Milica, Trajković Goran, The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia, null, 10.2298/VSP140526016S (ISSN 0042-8450) 0042-84501500016S.pdf
|
4. Borovcanin Milica, Jovanovic I., Dejanovic S., Radosavljevic Gordana, Arsenijevic Nebojsa, Lukic Miodrag, Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia, null, 10.1016/j.psyneuen.2015.03.003 (ISSN 0306-4530)
|
5. Curcic D., Stojmenović T., Djukić Dejanović S., Dikić N., Vesic-Vukasinovic M., Radivojevic N., Andjelkovic M., Borovcanin Milica, Djokic Gorica, Positive impact of prescribed physical activity on symptoms of schizophrenia: Randomized clinical trial, null, 10.24869/psyd.2017.459 (ISSN 0353-5053) 10.24869-psyd.2017.459.pdf
|
6. Janjić V., Radmanovic Branimir, Bukumirič Z., Dejanovic S., Muric Nemanja, Borovcanin Milica, Quality of life in primary insomnia: Three-week treatment with zolpidem vs. lorazepam, null, 10.1515/SJECR-2016-0077 (ISSN 1820-8665) 10.1515-SJECR-2016-0077.pdf
|
7. Borovcanin Milica, Janicijevic A., Jovanovic Ivan, Gajovic Nevena, Arsenijevic Nebojsa, Lukic Miodrag, IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis, null, 10.3389/fpsyt.2018.00271 (ISSN -)
|
8. Borovcanin N., Ristanović E., Todorovic Milos, Borovcanin Milica, Jovanovic Mirjana, Balint B., The use of complementary serological and molecular testing for blood-borne pathogens and evaluation of socio-demographic characteristics of intravenous drug users on substitution therapy from Šumadia district of Serbia, null, 10.2298/VSP170814129B (ISSN 0042-8450) 10.2298-VSP170814129B.pdf
|
9. Borovcanin Milica, Janićijević M., Jovanovic Ivan, Gajovic Nevena, Jurisevic Milena, Arsenijevic Nebojsa, Type 17 immune response facilitates progression of inflammation and correlates with cognition in stable schizophrenia, null, 10.3390/diagnostics10110926 (ISSN -)
|
10. Muric Nemanja, Arsenijevic Nebojsa, Borovcanin Milica, Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment, null, 10.3389/fpsyt.2020.612347 10.3389-fpsyt.2020.612347.pdf
|
11. Borovcanin Milica, Janićijević Aco, Mijailovic Natasa, Jovanovic Ivan, Arsenijevic Nebojsa, Vesić Katarina, Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia, null, 10.3389/fpsyt.2021.822579 (ISSN -)
|
| |
bookPart
|
1. Borovcanin Milica, Muric Nemanja, Milovanovic Marija, Milovanovic Jelena, Arsenijević Aleksandar, Arsenijevic Nebojsa, Vesić Katarina, Autoimmunity and psychosis, null, 10.1016/B978-0-323-85415-3.00011-8 (ISSN -)
|
| |
review
|
1. Borovcanin Milica, Jovanovic Ivan, Đukić Dejanovic Slavica, Radosavljevic Gordana, Arsenijevic Nebojsa, Lukic Miodrag, Possible role of TGF-B pathways in schizophrenia, null, 10.1515/SJECR-2015-0038 (ISSN 1820-8665) 10.1515_sjecr-2015-0038.pdf
|
2. Vesić Katarina, Dejanovic S., Borovcanin Milica, Samardzic J., Toncev Gordana, Cannabis as a possible treatment for spasticity in multiple sclerosis, null, 10.1515/SJECR-2015-0047 (ISSN 1820-8665) 10.1515-SJECR-2015-0047.pdf
|
3. Samardzic J., Borovcanin Milica, Dejanovic S., Jancić J., Djuric M., Obradović D., In vivo methodology in behavioural pharmacology - where are we now?, null, 10.2298/VSP150616106S (ISSN 0042-8450) 10.2298-VSP150616106S.pdf
|
4. Borovcanin Milica, Jovanovic I., Radosavljevic Gordana, Pantic Jelena, Janićijević M., Arsenijevic Nebojsa, Lukic Miodrag, Interleukin-6 in schizophrenia-Is there a therapeutic relevance?, null, 10.3389/fpsyt.2017.00221 10.3389-fpsyt.2017.00221.pdf
|
5. Borovcanin Milica, Radosavljevic Gordana, Pantic Jelena, Milovanovic Jelena, Mijailovic Natasa, Arsenijevic A., Arsenijevic Nebojsa, Contrasting roles of the galectin-3 in the schizophrenia onset, clinical presentation, and somatic comorbidity, null, 10.2174/1568026621666210611162420 (ISSN 1568-0266)
|
6. Mijailovic Natasa, Vesić Katarina, Borovcanin Milica, The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction, null, 10.3389/fpsyt.2022.828476 (ISSN -)
|
7. Mijailovic Natasa, Vesić Katarina, Arsenijevic D., Milojević-Rakić Maja, Borovcanin Milica, Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations, null, 10.3389/fncel.2022.923811 (ISSN 1662-5102) 10.3389-fncel.2022.923811.pdf
|
| |
Other
|
1. Janicijevic A., Dejanovic S., Borovcanin Milica, Interplay of Brain-Derived Neurotrophic Factor and Cytokines in Schizophrenia, null, 10.1515/sjecr-2017-0031 (ISSN 1820-8665) 10.1515-sjecr-2017-0031.pdf
|
2. Borovcanin Milica, Vesić Katarina, BALCIOGLU YASIN HASAN, Mijailovic Natasa, Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution, null, 10.3389/fpsyt.2022.1052710 (ISSN -)
|
